The Manhattan Regenerative Medicine Medical Group Announces Adult Stem Cell Public Seminars in Rumson, New Jersey and Manhattan, New York

Share Article

Upcoming Adult Stem Cell Lectures in Red Bank, NJ on Thursday, August 13, 2015; and Manhattan, NY on Friday, August 14, 2015.

News Image

The Manhattan Regenerative Medicine Medical Group announces a series of free public seminars on the use of adult stem cells for various degenerative and inflammatory conditions. They will be provided by Dr. Thomas A. Gionis, Surgeon-in-Chief and Dr. Nia Smyrniotis, Medical Director.

The seminars will be held on:

Thursday, August 13, 2015 at 11:00 am at the Molly Pitcher Inn, 88 Riverside Ave., Red Bank, NJ 07701

Friday, August 14, 2015 at 11:00 am at the Marriott Marquis – Manhattan, 1535 Broadway, New York, NY 10036.

Please RSVP at (917) 410-7391, all events are by reservation only.

The Manhattan Regenerative Medicine Medical Group (Manhattan, New York), along with sister affiliates, the Miami Stem Cell Treatment Center (Miami; Boca Raton; Orlando; The Villages; Sarasota, Florida) and, the Irvine Stem Cell Treatment Center (Irvine; Westlake Village; Sacramento, California), abide by approved investigational protocols using adult adipose derived stem cells (ADSCs) which can be deployed to improve patients’ quality of life for a number of chronic, degenerative and inflammatory conditions and diseases. ADSCs are taken from the patient’s own adipose (fat) tissue (found within a cellular mixture called stromal vascular fraction (SVF)). ADSCs are exceptionally abundant in adipose tissue. The adipose tissue is obtained from the patient during a 15 minute mini-liposuction performed under local anesthesia in the doctor’s office. SVF is a protein-rich solution containing mononuclear cell lines (predominantly adult autologous mesenchymal stem cells), macrophage cells, endothelial cells, red blood cells, and important Growth Factors that facilitate the stem cell process and promote their activity.

ADSCs are the body’s natural healing cells - they are recruited by chemical signals emitted by damaged tissues to repair and regenerate the body’s injured cells. The Manhattan Regenerative Medicine Medical Group only uses Adult Autologous Stem Cells from a person’s own fat – No embryonic stem cells are used; and No bone marrow stem cells are used. Current areas of study include: Emphysema, COPD, Asthma, Heart Failure, Heart Attack, Parkinson’s Disease, Stroke, Traumatic Brain Injury, Lou Gehrig’s Disease, Multiple Sclerosis, Lupus, Rheumatoid Arthritis, Crohn’s Disease, Muscular Dystrophy, Inflammatory Myopathies, and degenerative orthopedic joint conditions (Knee, Shoulder, Hip, Spine). For more information, or if someone thinks they may be a candidate for one of the adult stem cell protocols offered by the Manhattan Regenerative Medicine Medical Group, they may contact Dr. Gionis or Dr. Smyrniotis directly at (917) 410-7391, or see a complete list of the Center’s study areas at: http://www.nystemcellsusa.com.

Also, you can listen and call into our radio show, The Stem Cell Show, hosted by Dr. Gionis worldwide on KABC.com ("Listen Live" at 7pm EST) or the KABC app – available on the App Store or Google Play.

About the Manhattan Regenerative Medicine Medical Group: The Manhattan Regenerative Medicine Medical Group, along with sister affiliates, the Miami Stem Cell Treatment Center and the Irvine Stem Cell Treatment Center, is an affiliate of the California Stem Cell Treatment Center / Cell Surgical Network (CSN); we are located in Manhattan, New York. We provide care for people suffering from diseases that may be alleviated by access to adult stem cell based regenerative treatment. We utilize a fat transfer surgical technology to isolate and implant the patient’s own stem cells from a small quantity of fat harvested by a mini-liposuction on the same day. The investigational protocols utilized by the Manhattan Regenerative Medicine Medical Group have been reviewed and approved by an IRB (Institutional Review Board) which is registered with the U.S. Department of Health, Office of Human Research Protection (OHRP); and our studies are registered with Clinicaltrials.gov, a service of the U.S. National Institutes of Health (NIH). For more information, visit our websites: http://www.NYStemCellsUSA.com, http://www.MiamiStemCellsUSA.com, http://www.IrvineStemCellsUSA.com, or http://www.TheStemCellShow.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Dr. Thomas Gionis / Dr. Nia Smyrniotis
Miami/Irvine Stem Cell Treatment Center
Like >
Visit website